Article
Author(s):
Rochester, NY-The Technolas 217 Z Zyoptix Personalized Vision Correction system (Bausch & Lomb) was approved by the FDA for use in the United States last month (see related news on Page 1). About 99% of patients expressed extreme satisfaction or satisfaction with the visual results afforded them by the system, which may increase patient interest in refractive surgery.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.